Royal Philips, a global leader in health technology has announced the ...
GlaxoSmithKline plc (GSK) has announced positive results from the pivo...
The 10th annual Pneumonia and Diarrhea Progress Report Card has been l...
Avantor, Inc. and Ireland based National Institute of Bioprocessing Re...
Celgene Corporation and Acceleron Pharma Inc. have announced the U.S. ...
Abcam plc, a global innovator in life science reagents and tools, is p...
Mallinckrodt plc a global biopharmaceutical company has completed the ...
Abbott has announced that a team of its scientists identified a new su...
Bioeq IP AG has announced that it signed a license and development agr...
SciRhom GmbH, a therapeutic antibody company, has announced the develo...
BeiGene, Ltd. and Amgen have announced a global strate...
Children and adolescents (aged 6 to 17 years) living with type 1 diabe...
Scanwell Health, a modern diagnostics company has announced that its a...
AstraZeneca has agreed the sale and licence of the commercial rights t...
GlaxoSmithKline plc has announced that the European Commission ha...
GSK and IAVI reported that GSK’s M72/AS01E candidate vaccine sig...
Child Health Imprints (CHIL), the Singapore-based company focusing on&...
TetraScience, developers of the industry's first cloud-based data inte...
